• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布鲁氏菌属引起的布鲁氏菌病:银和金纳米颗粒的抗菌作用、潜在耐药性和毒性。

Brucella species-induced brucellosis: Antimicrobial effects, potential resistance and toxicity of silver and gold nanosized particles.

机构信息

Department of Public Health, College of Public Health and Health Informatics, Qassim University, Al-Bukairiyah, Saudi Arabia.

Department of Bacteriology, Mycology and Immunology, Faculty of Veterinary Medicine, University of Sadat City, Sadat City, Egypt.

出版信息

PLoS One. 2022 Jul 14;17(7):e0269963. doi: 10.1371/journal.pone.0269963. eCollection 2022.

DOI:10.1371/journal.pone.0269963
PMID:35834538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9282596/
Abstract

Brucellosis is an endemic zoonotic disease caused by Brucella species, which are intramacrophage pathogens that make treating this disease challenging. The negative effects of the treatment regime have prompted the development of new antimicrobials against brucellosis. A new treatment modality for antibiotic-resistant microorganisms is the use of nanoparticles (NPs). In this study, we examined the antibacterial activities of silver and gold NPs (SNPs and GNPs, respectively), the resistance developed by Brucella melitensis (B. melitensis) and Brucella abortus (B. abortus) strains and the toxicity of both of these NPs in experimental rats. To test the bactericidal effects of the SNPs and GNPs, we used 22 multidrug-resistant Brucella isolates (10 B. melitensis and 12 B. abortus). The minimal inhibitory concentrations (MICs) of both types of NPs were determined utilizing the microdilution technique. To test the stability of resistance, 7 B. melitensis and 6 B. abortus isolates were passaged ten times in culture with subinhibitory concentrations of NPs and another ten times without NPs. Histopathological analysis was completed after rats were given 0.25, 0.5, 1, and 2 mg/kg NPs orally for 28 consecutive days. The MIC values (μg/ml) of the 10-nm SNPs and 20-nm GNPs against B. melitensis were 22.43 ± 2.32 and 13.56 ± 1.22, while these values were 18.77 ± 1.33 and 12.45 ± 1.59 for B. abortus, respectively. After extensive in vitro exposure, most strains showed no resistance to the 10-nm SNPs or 20-nm GNPs. The NPs and antibiotics did not cross-react in any of the evolved Brucella strains. SNPs and GNPs at doses below 2 mg/kg were not harmful to rat tissue according to organ histopathological examinations. However, a greater dose of NPs (2 mg/kg) harmed all of the tissues studied. The bactericidal properties of NPs are demonstrated in this work. Brucella strains develop similar resistance to SNPs and GNPs, and at low dosages, neither SNPs nor GNPs were hazardous to rats.

摘要

布鲁氏菌病是一种由布鲁氏菌属引起的地方性人畜共患病,属于巨噬细胞内病原体,这使得治疗这种疾病具有挑战性。治疗方案的负面影响促使人们开发针对布鲁氏菌病的新抗菌药物。一种针对抗生素耐药微生物的新治疗方式是使用纳米颗粒(NPs)。在这项研究中,我们研究了银纳米颗粒(SNPs)和金纳米颗粒(GNPs)的抗菌活性、布鲁氏菌(B. melitensis)和布鲁氏菌(B. abortus)菌株的耐药性以及这两种 NPs 在实验大鼠中的毒性。为了测试 SNPs 和 GNPs 的杀菌效果,我们使用了 22 种多药耐药布鲁氏菌分离株(10 株 B. melitensis 和 12 株 B. abortus)。利用微量稀释技术确定了两种 NPs 的最小抑菌浓度(MICs)。为了测试耐药性的稳定性,将 7 株 B. melitensis 和 6 株 B. abortus 分离株在含有亚抑菌浓度 NPs 的培养基中传代 10 次,然后在不含 NPs 的培养基中传代 10 次。连续 28 天给大鼠口服 0.25、0.5、1 和 2 mg/kg NPs 后,进行组织病理学分析。10nm SNPs 和 20nm GNPs 对 B. melitensis 的 MIC 值(μg/ml)分别为 22.43±2.32 和 13.56±1.22,而对 B. abortus 的 MIC 值分别为 18.77±1.33 和 12.45±1.59。经过体外大量暴露,大多数菌株对 10nm SNPs 或 20nm GNPs 没有耐药性。在任何进化的布鲁氏菌株中,NPs 和抗生素都没有交叉反应。根据器官组织病理学检查,低于 2mg/kg 的 NPs 和抗生素对大鼠组织没有危害。然而,更高剂量的 NPs(2mg/kg)损害了所有研究的组织。本研究证明了 NPs 的杀菌特性。布鲁氏菌菌株对 SNPs 和 GNPs 产生相似的耐药性,而且在低剂量下,NPs 和 GNPs 对大鼠都没有危害。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/b84fc0a2e8e1/pone.0269963.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/ad06e26d1f82/pone.0269963.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/118574cfe824/pone.0269963.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/12b9ffc0fd91/pone.0269963.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/37be100f8989/pone.0269963.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/68b89a1d712d/pone.0269963.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/29b660238a43/pone.0269963.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/f96dd04febb8/pone.0269963.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/b84fc0a2e8e1/pone.0269963.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/ad06e26d1f82/pone.0269963.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/118574cfe824/pone.0269963.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/12b9ffc0fd91/pone.0269963.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/37be100f8989/pone.0269963.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/68b89a1d712d/pone.0269963.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/29b660238a43/pone.0269963.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/f96dd04febb8/pone.0269963.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c23/9282596/b84fc0a2e8e1/pone.0269963.g008.jpg

相似文献

1
Brucella species-induced brucellosis: Antimicrobial effects, potential resistance and toxicity of silver and gold nanosized particles.布鲁氏菌属引起的布鲁氏菌病:银和金纳米颗粒的抗菌作用、潜在耐药性和毒性。
PLoS One. 2022 Jul 14;17(7):e0269963. doi: 10.1371/journal.pone.0269963. eCollection 2022.
2
Prevalence of Brucella melitensis and Brucella abortus aminoglycoside-resistant isolates: a systematic review and meta-analysis.绵羊附睾和牛型布鲁氏菌氨基糖苷类耐药株的流行率:系统评价和荟萃分析。
Braz J Microbiol. 2024 Mar;55(1):429-439. doi: 10.1007/s42770-023-01233-6. Epub 2024 Jan 16.
3
In vitro antimicrobial susceptibility of Brucella species.布鲁氏菌属的体外抗菌药敏性
Int J Antimicrob Agents. 2004 Apr;23(4):405-7. doi: 10.1016/j.ijantimicag.2003.09.024.
4
Antibacterial effects and resistance induction of silver and gold nanoparticles against Staphylococcus aureus-induced mastitis and the potential toxicity in rats.银和金纳米粒子对金黄色葡萄球菌诱导的乳腺炎的抗菌作用和耐药性诱导,以及在大鼠中的潜在毒性。
Microbiologyopen. 2019 Apr;8(4):e00698. doi: 10.1002/mbo3.698. Epub 2018 Aug 5.
5
Epidemiologically characteristics of human brucellosis and antimicrobial susceptibility pattern of Brucella melitensis in Hinggan League of the Inner Mongolia Autonomous Region, China.中国内蒙古自治区兴安盟人间布鲁氏菌病的流行病学特征及布鲁氏菌药敏模式。
Infect Dis Poverty. 2020 Jun 29;9(1):79. doi: 10.1186/s40249-020-00697-0.
6
Bactericidal Effect of Silver Nanoparticles on Intramacrophage Brucella abortus 544.银纳米颗粒对巨噬细胞内流产布鲁氏菌544的杀菌作用
Jundishapur J Microbiol. 2014 Mar;7(3):e9039. doi: 10.5812/jjm.9039. Epub 2014 Mar 1.
7
Genetic diversity of Brucella abortus and Brucella melitensis in Kazakhstan using MLVA-16.利用16个多 locus 可变数目串联重复序列分析(MLVA-16)对哈萨克斯坦流产布鲁氏菌和羊种布鲁氏菌的遗传多样性进行研究。
Infect Genet Evol. 2015 Aug;34:173-80. doi: 10.1016/j.meegid.2015.07.008. Epub 2015 Jul 6.
8
Prevalence of and Fluoroquinolones Resistant Isolates: A Systematic Review and Meta-Analysis.和氟喹诺酮类耐药分离株的流行率:系统评价和荟萃分析。
Vector Borne Zoonotic Dis. 2024 Jan;24(1):1-9. doi: 10.1089/vbz.2023.0063. Epub 2023 Oct 20.
9
In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.土耳其分离的布鲁氏菌对各种抗菌药物的体外活性。
Infect Dis (Lond). 2015 Jun;47(6):364-9. doi: 10.3109/00365548.2014.988748. Epub 2015 Feb 24.
10
Phylogenetic Analysis and Comparative Genomics of Brucella abortus and Brucella melitensis Strains in Egypt.埃及流产布鲁氏菌和马耳他布鲁氏菌菌株的系统发育分析和比较基因组学。
J Mol Evol. 2024 Jun;92(3):338-357. doi: 10.1007/s00239-024-10173-0. Epub 2024 May 29.

引用本文的文献

1
Brucellosis in the omics era: integrative perspectives on Brucella genomic architecture, host-pathogen interactions, and disease dynamics.组学时代的布鲁氏菌病:关于布鲁氏菌基因组结构、宿主-病原体相互作用及疾病动态的综合观点
World J Microbiol Biotechnol. 2025 Jul 11;41(7):264. doi: 10.1007/s11274-025-04484-7.
2
Seroprevalence of brucellosis in camels and humans in the Al-Qassim region of Saudi Arabia and its implications for public health.沙特阿拉伯卡西姆地区骆驼和人类布鲁氏菌病血清流行率及其对公共卫生的影响。
AMB Express. 2025 Feb 7;15(1):22. doi: 10.1186/s13568-025-01822-8.
3
Unravelling the challenge of cotrimoxazole and rifampin resistance in B. melitensis and B. abortus: A systematic review and meta-analysis.

本文引用的文献

1
Alternatives to Conventional Antibiotic Therapy: Potential Therapeutic Strategies of Combating Antimicrobial-Resistance and Biofilm-Related Infections.替代传统抗生素治疗:对抗抗微生物耐药性和生物膜相关感染的潜在治疗策略。
Mol Biotechnol. 2021 Dec;63(12):1103-1124. doi: 10.1007/s12033-021-00371-2. Epub 2021 Jul 26.
2
Noncytotoxic silver nanoparticles as a new antimicrobial strategy.非细胞毒性银纳米颗粒作为一种新的抗菌策略。
Sci Rep. 2021 Jun 29;11(1):13451. doi: 10.1038/s41598-021-92812-w.
3
Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects.
揭示羊布鲁氏菌和牛布鲁氏菌对复方新诺明和利福平耐药性的挑战:一项系统评价和荟萃分析。
PLoS Negl Trop Dis. 2024 Dec 2;18(12):e0012630. doi: 10.1371/journal.pntd.0012630. eCollection 2024 Dec.
4
Co-delivery of doxycycline and rifampicin using CdTe-labeled poly (lactic-co-glycolic) acid for treatment of Brucella melitensis infection.使用碲化镉标记的聚乳酸-乙醇酸共聚物共递送强力霉素和利福平用于治疗羊种布鲁氏菌感染。
BMC Chem. 2024 May 15;18(1):100. doi: 10.1186/s13065-024-01200-8.
5
Prevalence of Brucella melitensis and Brucella abortus aminoglycoside-resistant isolates: a systematic review and meta-analysis.绵羊附睾和牛型布鲁氏菌氨基糖苷类耐药株的流行率:系统评价和荟萃分析。
Braz J Microbiol. 2024 Mar;55(1):429-439. doi: 10.1007/s42770-023-01233-6. Epub 2024 Jan 16.
6
Brucellae as resilient intracellular pathogens: epidemiology, host-pathogen interaction, recent genomics and proteomics approaches, and future perspectives.布鲁氏菌作为顽强的细胞内病原体:流行病学、宿主-病原体相互作用、近期的基因组学和蛋白质组学方法以及未来展望。
Front Vet Sci. 2023 Oct 9;10:1255239. doi: 10.3389/fvets.2023.1255239. eCollection 2023.
7
Co-delivery of streptomycin and hydroxychloroquine by labeled solid lipid nanoparticles to treat brucellosis: an animal study.标记固体脂质纳米粒共载链霉素和羟氯喹治疗布鲁氏菌病的动物研究。
Sci Rep. 2023 Aug 28;13(1):14012. doi: 10.1038/s41598-023-41150-0.
8
The Development of Diagnostic and Vaccine Strategies for Early Detection and Control of Human Brucellosis, Particularly in Endemic Areas.人类布鲁氏菌病早期检测与控制的诊断及疫苗策略的发展,特别是在流行地区。
Vaccines (Basel). 2023 Mar 14;11(3):654. doi: 10.3390/vaccines11030654.
9
The Development of Technology to Prevent, Diagnose, and Manage Antimicrobial Resistance in Healthcare-Associated Infections.预防、诊断和管理医疗相关感染中抗菌药物耐药性的技术发展
Vaccines (Basel). 2022 Dec 8;10(12):2100. doi: 10.3390/vaccines10122100.
纳米颗粒作为治疗多重耐药菌的治疗选择:研究进展、挑战和前景。
World J Microbiol Biotechnol. 2021 May 28;37(6):108. doi: 10.1007/s11274-021-03070-x.
4
Nanoparticles as antimicrobial and antiviral agents: A literature-based perspective study.纳米颗粒作为抗菌和抗病毒剂:一项基于文献的前瞻性研究。
Heliyon. 2021 Mar 13;7(3):e06456. doi: 10.1016/j.heliyon.2021.e06456. eCollection 2021 Mar.
5
Green synthesis of silver nanoparticles by leaf extract to tackle growth of species and other perilous pathogens.利用叶提取物绿色合成银纳米颗粒以应对物种生长及其他危险病原体。
Saudi J Biol Sci. 2021 Jan;28(1):495-503. doi: 10.1016/j.sjbs.2020.10.034. Epub 2020 Oct 28.
6
Natural compounds and extracts as novel antimicrobial agents.天然化合物和提取物作为新型抗菌剂。
Expert Opin Ther Pat. 2020 Dec;30(12):949-962. doi: 10.1080/13543776.2020.1853101.
7
Trends, Epidemiology, and Management of Multi-Drug Resistant Gram-Negative Bacterial Infections in the Hospitalized Setting.住院患者中多重耐药革兰氏阴性菌感染的趋势、流行病学及管理
Antibiotics (Basel). 2020 Apr 20;9(4):196. doi: 10.3390/antibiotics9040196.
8
Toxicity of Microplastics and Nanoplastics in Mammalian Systems.哺乳动物系统中微塑料和纳米塑料的毒性。
Int J Environ Res Public Health. 2020 Feb 26;17(5):1509. doi: 10.3390/ijerph17051509.
9
Molecular Mechanisms of Bacterial Resistance to Metal and Metal Oxide Nanoparticles.金属和金属氧化物纳米颗粒耐药的分子机制。
Int J Mol Sci. 2019 Jun 8;20(11):2808. doi: 10.3390/ijms20112808.
10
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.抗菌药物耐药时代对抗ESKAPE病原体的新兴策略:综述
Front Microbiol. 2019 Apr 1;10:539. doi: 10.3389/fmicb.2019.00539. eCollection 2019.